2019-10026. Bulk Manufacturer of Controlled Substances Registration  

  • Start Preamble

    ACTION:

    Notice of registration.

    SUMMARY:

    The registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as bulk manufacturers of schedule I and II controlled substances.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The companies listed below applied to be registered as bulk manufacturers of schedule I or schedule II controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted for these notices.

    CompanyFR docketPublished
    Johnson Matthey, Inc84 FR 5477February 21, 2019.
    Stepan Company84 FR 5499February 21, 2019.
    Research Triangle Institute84 FR 5501February 21, 2019.

    The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of the registrants to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.

    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed companies.

    Start Signature

    Dated: April 27, 2019.

    John J. Martin,

    Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2019-10026 Filed 5-14-19; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
05/15/2019
Department:
Justice Department
Agency:
Drug Enforcement Administration
EntryType:
Notice
Action:
Notice of registration.
Document Number:
2019-10026
Pages:
21814-21814 (1 pages)
Docket Numbers:
Docket No. DEA-392
SectionNoes:
PDF File:
2019-10026.pdf